Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer
Patients with human papillomavirus –associated head and neck cancers who respond well to induction therapy can receive substantially lower doses of radiation and still achieve good safety and efficacy outcomes, according to a new phase II trial.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Tags: Head & Neck Cancer News Radiation Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Genital Warts | Head and Neck Cancer | Human Papillomavirus (HPV)